Interview

Hunger For New Drugs, Tech To Drive 2019 Pharma M&A

By Chelsea Naso (January 17, 2019, 7:05 PM EST) -- Bristol-Myers Squibb made headlines this month with its mammoth takeover of Celgene, but the vast majority of dealmaking in the life sciences space this year will be smaller transactions aimed at acquiring promising drug therapies and technologies, according to Asher Rubin, global head of Hogan Lovells LLP's life sciences industry group.  ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!